As a considerable proportion of cancers across various locations exhibit increased FSHR expression in endothelial cells, further research should be aimed at developing advanced diagnostic methods that enable precise localization of primary tumors and metastatic lesions, predictive assessment, and accurate determination of the scope of surgical procedures. This evidence concerns the gene FSHR and cancer.